Search

Your search keyword '"van der Woude, C. Janneke"' showing total 619 results

Search Constraints

Start Over You searched for: Author "van der Woude, C. Janneke" Remove constraint Author: "van der Woude, C. Janneke"
619 results on '"van der Woude, C. Janneke"'

Search Results

3. A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial

4. Evaluation of walking activity and gait to identify physical and mental fatigue in neurodegenerative and immune disorders: preliminary insights from the IDEA-FAST feasibility study

6. Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease

7. Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial

8. Endoscopic management of patients with high-risk colorectal colitis–associated neoplasia: a Delphi study

9. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

11. Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study

12. Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

13. Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease.

15. Retreatment with anti-tumor necrosis factor therapy in combination with an immunomodulator for recurrence of Crohn’s disease after ileocecal resection results in prolonged continuation as compared to anti-tumor necrosis factor monotherapy

17. Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease

18. Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn’s disease

19. Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease

22. A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process

26. Prognostic Value of the Modified Rutgeerts Score for Long-Term Outcomes After Primary Ileocecal Resection in Crohn's Disease.

27. Impact of timing of primary ileocecal resection on prognosis in patients with Crohn’s disease

28. Identification of Fatigue and Sleepiness in Immune and Neurodegenerative Disorders from Measures of Real-World Gait Variability

29. Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies

35. Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

36. Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial

40. Effect of Cognitive Behavioral Therapy on Clinical Disease Course in Adolescents and Young Adults With Inflammatory Bowel Disease and Subclinical Anxiety and/or Depression: Results of a Randomized Trial

43. 115 - ACONTECIMIENTOS ADVERSOS TROMBOEMBÓLICOS, CARDIOVASCULARES MAYORES ENTRE LOS PACIENTES INCLUIDOS EN EL PROGRAMA DE ENSAYOS CLÍNICOS DE FILGOTINIB

46. sj-docx-1-tag-10.1177_17562848231174295 – Supplemental material for SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis

Catalog

Books, media, physical & digital resources